Clinical and Experimental Rheumatology
Clinical and Experimental Rheumatology is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 112. It has an SJR impact factor of 1,004 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,004.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
1,004
H-index
112
Docs (year)
317
Docs 3y
1167
Total refs
10906
Cites 3y
3004
Citable 3y
922
Cites/Doc 2y
2.66
Ref/Doc
34.4
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
COVID-19: the new challenge for rheumatologists
One year in review 2022: systemic lupus erythematosus
JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis
Fibromyalgia in women: somatisation or stress-evoked, sex-dimorphic neuropathic pain?
Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection
Defining anti-synthetase syndrome: a systematic literature review
Fibromyalgia position paper
Evidence for uncoupling of clinical and 18-FDG activity of PET/CT scan improvement in tocilizumab-treated patients with large-vessel giant cell arteritis
Pathogenesis of rheumatoid arthritis: one year in review 2022
One year in review 2020: novelties in the treatment of rheumatoid arthritis
The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature
The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome
One year in review 2021: fibromyalgia
Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management
Physical and mental impact of COVID-19 outbreak on fibromyalgia patients
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study
Juvenile dermatomyositis. Where are we now?
One year in review 2021: pathogenesis of rheumatoid arthritis
Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Treatment of relapsing polychondritis: a systematic review
Pain and transition: evaluating fibromyalgia in transgender individuals
One year in review 2021: Sjögren's syndrome
SARS-CoV-2 infection in patients with systemic autoimmune diseases